Bone disease in eliglustat treated Gaucher disease type 1 patients: A real-world experience in a tertiary referral hospital

被引:0
|
作者
Valls-Villalba, Angel [1 ]
Camprodon-Gomez, Maria [2 ]
Moreno-Martinez, Daniel [3 ]
Hernandez-Vara, Jorge [4 ]
Arranz-Amo, Jose Antonio [5 ]
Carnicer-Caceres, Clara [5 ]
机构
[1] Vall Hebron Univ Hosp, Internal Med, Barcelona, Spain
[2] Vall DHebron Univ Hosp, Unit Rare Dis & Metab Hereditary Disorders, Barcelona, Spain
[3] Vall Hebron Univ Hosp, Dept Radiol, Barcelona, Spain
[4] Vall Hebron Univ Hosp, Dept Neurol, Unit Movement Disorders, Barcelona, Spain
[5] Vall Hebron Univ Hosp, Inborn Error Metab Lab, Barcelona, Spain
关键词
D O I
10.1016/j.ymgme.2022.107340
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
357
引用
收藏
页码:129 / 129
页数:1
相关论文
共 50 条
  • [41] Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1 The ENGAGE Randomized Clinical Trial
    Mistry, Pramod K.
    Lukina, Elena
    Ben Turkia, Hadhami
    Amato, Dominick
    Baris, Hagit
    Dasouki, Majed
    Ghosn, Marwan
    Mehta, Atul
    Packman, Seymour
    Pastores, Gregory
    Petakov, Milan
    Assouline, Sarit
    Balwani, Manisha
    Danda, Sumita
    Hadjiev, Evgueniy
    Ortega, Andres
    Shankar, Suma
    Helena Solano, Maria
    Ross, Leorah
    Angell, Jennifer
    Peterschmitt, M. Judith
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (07): : 695 - 706
  • [42] Evaluation of glucosylsphingosine as a biomarker of the eliglustat treatment response in patients with Gaucher disease type 1 (GD1)
    Peterschmitt, M. Judith
    Zhang, Kate
    Liu, Lin
    Cox, Gerald F.
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S94 - S95
  • [43] Genetic kidney disease in pregnancy - experience of tertiary referral hospital
    Marchao, Natalia
    Da Costa, Jose Oliveira
    Peres, Nadiesda
    Godinho, Iolanda
    Jorge, Sofia
    Rodrigues, Marcia
    Goncalves, Sara
    Fonseca, Jose Agapito
    Centeno, Monica
    Lopes, Jose Antonio
    Pinto, Luisa
    Nogueira, Estela
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2135 - I2135
  • [44] Genetic kidney disease in pregnancy - experience of tertiary referral hospital
    Marchao, Natalia
    Da Costa, Jose Oliveira
    Peres, Nadiesda
    Godinho, Iolanda
    Jorge, Sofia
    Rodrigues, Marcia
    Goncalves, Sara
    Fonseca, Jose Agapito
    Centeno, Monica
    Lopes, Jose Antonio
    Pinto, Luisa
    Nogueira, Estela
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [45] Real-World Experience of Patients With Sickle Cell Disease Treated With Voxelotor: A Multicenter, Retrospective Study
    Andemariam, Biree
    Osunkwo, Ifeyinwa
    Idowu, Modupe
    Shah, Nirmish
    Drachtman, Richard
    Sharma, Archana
    Glaros, Alexander
    Achebe, Maureen
    Nero, Alecia
    Curtis, Susanna
    Minniti, Caterina
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 134 - 135
  • [46] Real-World Experience of Patients with Sickle Cell Disease Treated with Voxelotor: A Multicenter, Retrospective Study
    Andemariam, Biree
    Achebe, Maureen
    Clay, E. Leila Jerome
    Drachtman, Richard A.
    Sharma, Archana
    Nero, Alecia C.
    Osunkwo, Ifeyinwa
    Sarnaik, Sharada
    Idowu, Modupe
    Shah, Nirmish
    Curtis, Susanna A.
    Minniti, Caterina
    BLOOD, 2021, 138
  • [47] Management and monitoring recommendations for the use of eliglustat in adults with type 1 Gaucher disease in Europe
    Belmatoug, Nadia
    Di Rocco, Maja
    Fraga, Cristina
    Giraldo, Pilar
    Hughes, Derralynn
    Lukina, Elena
    Maison-Blanche, Pierre
    Merkel, Martin
    Niederau, Claus
    Plockinger, Ursula
    Richter, Johan
    Stulnig, Thomas M.
    Dahl, Stephan vom
    Cox, Timothy M.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 37 : 25 - 32
  • [48] Bone density in Type 1 Gaucher disease
    Pastores, GM
    Wallenstein, S
    Desnick, RJ
    Luckey, MM
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 (11) : 1801 - 1807
  • [49] Budget Impact Analysis of Eliglustat for the Treatment of Gaucher Disease Type 1 in the United States
    Nalysnyk, Luba
    Sugarman, Rebecca
    Cele, Clifford
    Uyei, Jennifer
    Ward, Alexandra
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (10): : 1002 - 1008
  • [50] Recommendations for the use of eliglustat in the treatment of adults with Gaucher disease type 1 in the United States
    Balwani, Manisha
    Burrow, Thomas Andrew
    Charrow, Joel
    Goker-Alpan, Ozlem
    Kaplan, Paige
    Kishnani, Priya S.
    Mistry, Pramod
    Ruskin, Jeremy
    Weinreb, Neal
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : 95 - 103